David Lawson is Director of Medical Technology at the Department of Health and Social Care. In this role, Mr Lawson is the Government policy lead for Medical Technology with responsibility for the implementation of the Government's inaugural Medical Technology Strategy published in February last year. Key initiatives include implementation of a rules based innovation pathway to accelerate adoption of MedTech, implementation of a national Product Information Management (PIM) system and reform of the £1.3 billion Part IX Drug Tariff used to prescribe MedTech in primary care. David is also SRO for the Innovative Devices Access Pathway (IDAP) which was launched in September to apply a joined up approach across MHRA, NICE, NHSE and devolved administrations for novel technology and SRO for the £424 million Ambulance Radio Programme.
Matchmaking Information
Attending
Insights Stage
Beyond Price: How Value-Based Procurement is Reshaping NHS MedTech
This session explores the principles underpinning value-based procurement in MedTech, the evidence supporting its adoption, and the NHS’s plans for rolling it out across England. Chaired by Chris Whitehouse, it brings together senior voices from the Department of Health and Social Care, industry and clinical practice to examine a new assessment methodology for MedTech device procurement — developed in collaboration with DHSC’s Medical Technology and Innovation Unit. Speakers will explore the benefits the new approach can deliver, the challenges that remain, and what it means in practice for suppliers, clinicians and commissioners.
